Document Detail


Troponin after cardiac surgery: a predictor or a phenomenon?
MedLine Citation:
PMID:  18355525     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Increased cardiac troponin is observed after virtually every cardiac operation, indicating perioperative myocardial injury. The clinical significance of this elevation is controversial. This study aimed to correlate postoperative troponin levels with major adverse cardiac events (MACE). METHODS: The study included 1918 consecutive patients undergoing adult cardiac operations, including 1515 isolated coronary procedures, 229 valvular operations, and 174 combined coronary/valve procedures. Peak troponin T (normal value < 0.1 microg/L) was measured at less than 24 hours postoperatively. Excluded were 506 patients with a recent myocardial infarction (< 30-days of operation). The primary outcome was a composite of death, electrocardiogram-defined infarction, and low output syndrome (MACE). RESULTS: Mortality rates were 1.4%, 6.1%, and 7% in the coronary bypass, valve, and combined groups, respectively (p < 0.001). The rates of MACE were 17%, 35%, and 44% (p < 0.0001), and mean troponin T levels were 0.9 +/- 1.5, 1.2 +/- 2.9, and 1.3 +/- 1.2 microg/L (p < 0.001), in the coronary bypass, valve, and combined groups, respectively. All patients were divided into quintiles based on their peak postoperative troponin level (Q1, 0.0 to 0.39; Q2, 0.4 to 0.59; Q3, 0.6 to 0.79; Q4, 0.8 to 1.29; and Q5, > 1.3 microg/L). Adverse outcomes were similar and stable in the lower quintiles. A stepwise increase in adverse outcomes was observed in the higher quintiles. Receiver operating characteristic curve analysis revealed a troponin cutoff of 0.8 microg/L was the most discriminatory for MACE (area under the curve, 0.7). Multivariable analyses showed a troponin value of more than 0.8 microg/L was independently associated with MACE. CONCLUSIONS: Moderate elevations in troponin are common after cardiac operations; troponin is a well-described predictor of outcomes. Troponin levels exceeding 0.8 microg/L are associated with increased MACE in patients without a history of preoperative myocardial infarction within 30 days of operation.
Authors:
Nahum Nesher; Abdullah A Alghamdi; Steve K Singh; Jeri Y Sever; George T Christakis; Bernard S Goldman; Gideon N Cohen; Fuad Moussa; Stephen E Fremes
Related Documents :
21214105 - The effect of amiodarone on cardiac rhythm after cardiopulmonary bypass in patients wit...
8787705 - Fluoroenzymometric method to measure cardiac troponin i in sera of patients with myocar...
23529625 - Initial culprit-only versus initial multivessel percutaneous coronary intervention in p...
7776775 - Alpha-ketoglutarate for myocardial protection in heart surgery.
1739525 - Value of ambulatory st segment monitoring in patients with chronic stable angina: does ...
7229655 - Arachidonate-induced experimental nerve infarction.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Annals of thoracic surgery     Volume:  85     ISSN:  1552-6259     ISO Abbreviation:  Ann. Thorac. Surg.     Publication Date:  2008 Apr 
Date Detail:
Created Date:  2008-03-21     Completed Date:  2008-04-16     Revised Date:  2009-02-05    
Medline Journal Info:
Nlm Unique ID:  15030100R     Medline TA:  Ann Thorac Surg     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1348-54     Citation Subset:  AIM; IM    
Affiliation:
Division of Cardiac and Vascular Surgery, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. nachumnesher@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Biological Markers / blood
Cardiac Surgical Procedures / methods,  mortality*
Cohort Studies
Coronary Artery Bypass / methods,  mortality
Female
Heart Valve Prosthesis Implantation / adverse effects,  methods
Humans
Male
Middle Aged
Multivariate Analysis
Postoperative Complications / blood*,  mortality
Postoperative Period
Prognosis
ROC Curve
Retrospective Studies
Risk Assessment
Sensitivity and Specificity
Survival Analysis
Treatment Outcome
Troponin I / blood*
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Troponin I
Comments/Corrections
Comment In:
Ann Thorac Surg. 2008 Apr;85(4):1354   [PMID:  18355526 ]
Ann Thorac Surg. 2008 Nov;86(5):1721   [PMID:  19049792 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surgical treatment for postinfarction left ventricular free wall rupture.
Next Document:  Use of negative extrathoracic pressure to improve hemodynamics after cardiac surgery.